feed,title,long_url,short_url
Motley,Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.,https://www.fool.com/investing/2023/12/16/ozempic-zepbound-eli-lilly-stock-better-buy/?source=iedfolrf0000001,https://da.gd/0UCiHK
